ICICI Lombard General Insurance Company Limited (ICICIGI) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

CompoundingAI Research Updated July 12, 2026 3 min read

ICICI Lombard General Insurance enters the Q1 FY2027 results period riding the tailwinds of record-breaking domestic auto sales and a favorable shift in bond yields. Investors will be looking for signs of sustained growth in the retail health segment and whether the company's underwriting discipline has managed to offset the ongoing absence of a comprehensive motor third-party tariff hike.

Quick Details
Results dateJuly 17, 2026
QuarterQ1 FY 2026-2027
Previous quarter revenueRs. 73.40 billion
Previous quarter PATRs. 5.47 billion
Previous quarter EBITDA marginNot applicable
Market capRs. 91,187.59 Cr
CMPRs. 1,826.2

ICICI Lombard General Insurance Company Limited Q1 Results Date and Time

The board meeting is scheduled for July 15, 2026, to consider and approve the audited financial results for the quarter ending June 30, 2026.

What to expect from ICICI Lombard General Insurance Company Limited's Q1 FY27 results

The company faces a strong growth tailwind in the motor segment, supported by record-breaking PV and 2W sales volumes throughout the April–June 2026 period. Investment income is expected to benefit from the sharp 33 bps decline in the 10-year benchmark bond yield observed between the May peak and June-end, which supports MTM gains on the Rs. 584.21 billion investment portfolio. While the retail health segment continues to expand through Tier 2 and Tier 3 city penetration, the motor third-party loss ratio remains under pressure as no comprehensive tariff hike was implemented during the quarter. Management remains focused on its strategic ROAE target of 18-20% and is expected to discuss the path toward the guided 300-450 bps improvement in the combined ratio following the eventual adoption of Ind AS 117.

Key Things To Watch

Performance vs Guidance Tracking: Tracking progress against management's stated annual targets.

  • GDPI growth vs industry — 100-200 bps higher — Not met in FY2026
  • ROAE — 18-20% target — 17.8% achieved in FY2026
  • Motor loss ratio — 65%-67% range — 66.3% achieved in FY2026
  • Retail Health loss ratio — 65%-70% range — 64.6% achieved in FY2026

Motor TP Pricing and Loss Ratios: Monitoring the impact of pricing pressures on long-tail risks.

  • No comprehensive motor TP tariff hike implemented during Q1 FY2027
  • Motor TP loss ratio stood at 63.8% for FY2026
  • Management awaiting industry-wide price hike announcement after post-quarter review signals

Health Insurance Profitability: Evaluating the sustainability of the retail health indemnity business.

  • Retail Health indemnity loss ratio maintained at 64.6% in FY2026
  • Focus on Tier 2 and Tier 3 city expansion to drive retail growth
  • Elevate product traction remains a key driver for segment expansion

Combined Ratio Trajectory: Assessing operational efficiency and Ind AS transition.

  • Combined ratio improved to 101.2% in Q4 FY2026 from 103.4% in FY2026
  • Ind AS 117 adoption expected to improve combined ratio by 300-450 bps
  • Management continues to operate within the 30% EOM regulatory limit

Frequently Asked Questions

What drove the improvement in the retail health loss ratio?

The retail health indemnity loss ratio improved to 64.6% in FY2026 from 67.9% in FY2025. This performance remains within the management's comfortable steady-state range of 65%-70%.

How did the investment portfolio perform in the context of bond yields?

The investment portfolio reached Rs. 584.21 billion as of March 31, 2026, with a duration of approximately 4.74 years and a YTM of 7.39%. Falling bond yields in June 2026 provided a tailwind for MTM gains on this fixed-income book.

What is the status of the company's motor market share?

The motor market share was 10.7% in FY2026, maintaining the company's position as the top player. Management has noted that share fluctuations are partly due to tactical decisions to let go of unprofitable business.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now